CalciMedica (CALC) Other Operating Expenses (2022 - 2025)

CalciMedica's (CALC) quarterly Other Operating Expenses came in at -$21000.0 in Q4 2025, down 100.98% on a QoQ basis from $2.1 million in Q4 2022.

CalciMedica (CALC) Other Operating Expenses (2022 - 2025) Analysis & Trends

CalciMedica (CALC) has 2 years of Other Operating Expenses data on file, last reported at -$21000.0 in Q4 2025.

Quarterly Other Operating Expenses changed N/A year-over-year to -$21000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$21000.0 (changed N/A YoY) and the FY2025 annual result came in at -$21000.0, changed N/A from the prior year.
Other Operating Expenses fell to -$21000.0 in Q4 2025, from $2.1 million in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $2.1 million in Q4 2022 to a low of -$101000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	CalciMedica	9.80 Mn	-8.82 Mn	-

Download Data